Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2019-02-01 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhengzhou Antu Biological Engineering Co., Ltd. regarding the progress of cash management using idle funds. It details the company's purchase and redemption of various financial products such as wealth management products, structured deposits, and fixed deposits. The document includes specific dates, amounts, and yields but does not contain comprehensive financial statements or detailed financial analysis. It is a regulatory announcement about financing activities related to cash management and investment of idle funds. The document length is relatively short (2420 characters), and it is not a full financial report but an update on capital usage and financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-02-01 Chinese
使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the company's use of idle raised funds for cash management, detailing purchases and redemptions of financial products. It includes specific dates, amounts, and banks involved but does not contain comprehensive financial statements or detailed financial performance analysis. The document length is short (1318 characters) and it serves as an update on financing activities related to the company's raised funds. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or regulatory filing.
2019-02-01 Chinese
2018年年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2018 annual performance forecast (业绩预告) from Zhengzhou Antu Bioengineering Co., Ltd. It provides preliminary estimated financial results for the full year 2018, including expected revenue and net profit increases compared to the previous year. It explicitly states that the forecast has not been audited and that the final audited annual report will be disclosed later. The document is short (1044 characters) and serves as a performance outlook rather than a full financial report. This type of document is typically classified as an Earnings Release (ER) because it announces key financial results highlights for a fiscal period but is not a comprehensive annual report (10-K) or interim report (IR). FY 2018
2019-01-30 Chinese
关于全资子公司完成医疗器械生产许可证变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of a change in the medical device production license for a wholly-owned subsidiary. It includes details about the license change, new product registration, and its potential impact on the company. There is no financial data, no mention of a report being attached or published, and no regulatory certification or voting results. The content is an official announcement about a regulatory approval/licensing update, which does not fit into financial reports or other specific categories. Therefore, it best fits under Regulatory Filings (RNS) as a general regulatory announcement.
2019-01-28 Chinese
关于控股子公司完成医疗器械生产许可证变更登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of a change in the medical device production license for a controlling subsidiary. It details the new production address and license information, and states the impact on the company. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, no legal proceedings, or other report types. The document is a regulatory announcement about a license change, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories. The document length is short and it is not a report publication announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2019-01-21 Chinese
关于控股孙公司取得医疗器械经营许可证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a medical device business license by a controlling subsidiary. It is a regulatory update about business operations and licensing, not a financial report, earnings release, or management discussion. The document is short (853 characters) and serves as an official announcement of a regulatory approval. It does not contain financial data, management changes, or voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-01-16 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.